speb/financial-data huggingface dataset:
ADN1.DE income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: -7198000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Retained Earnings: 155614000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Sale Of Business: 128000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 19000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Sale Of Investment: 1179000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Sale Of PPE: 321000.00
ADN1.DE income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 7942000.00
ADN1.DE income_statement (annual, 2022-12-31) — Selling General And Administration: 24690000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Share Issued: 6512272.00
ADN1.DE income_statement (annual, 2022-12-31) — Special Income Charges: 7942000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 210034000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 85343000.00
ADN1.DE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 2525120.00
ADN1.DE income_statement (annual, 2022-12-31) — Tax Provision: 13289000.00
ADN1.DE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.32
ADN1.DE balance_sheet (annual, 2022-12-31) — Taxes Receivable: 3330000.00
ADN1.DE cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -15706000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Assets: 655565000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Capitalization: 210034000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Debt: 137455000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 215181000.00
ADN1.DE income_statement (annual, 2022-12-31) — Total Expenses: 861364000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 440384000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 315899000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 225933000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 35587000.00
ADN1.DE income_statement (annual, 2022-12-31) — Total Unusual Items: 7891000.00
ADN1.DE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 7891000.00
ADN1.DE balance_sheet (annual, 2022-12-31) — Working Capital: 125215000.00
ADN1.DE income_statement (annual, 2022-12-31) — Write Off: 182000.00
ADN1.DE income_statement (annual, 2023-12-31) — +Operating Expense: 306292000.00
ADN1.DE income_statement (annual, 2023-12-31) — +Total Revenue: 1135903000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Accounts Payable: 46335000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 181893000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -43731000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 45690000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 11905000.00
ADN1.DE income_statement (annual, 2023-12-31) — Basic Average Shares: 6515102.00
ADN1.DE income_statement (annual, 2023-12-31) — Basic EPS: 0.49
ADN1.DE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 90897000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 150708000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Capital Expenditure: -34345000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 178823000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Capital Stock: 6520000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 100772000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 103056000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -5283000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Cash Financial: 100772000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 10967000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Change In Working Capital: 13024000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Changes In Cash: 10189000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Common Stock: 6520000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -5283000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Common Stock Equity: 194416000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 417000.00
ADN1.DE income_statement (annual, 2023-12-31) — Cost Of Revenue: 811768000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Current Assets: 386609000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 31031000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Current Debt: 8367000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 31031000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Current Liabilities: 280176000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Current Provisions: 9573000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Depreciation: 57723000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 57723000.00
ADN1.DE income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 57723000.00
ADN1.DE income_statement (annual, 2023-12-31) — Depreciation Income Statement: 57723000.00
ADN1.DE income_statement (annual, 2023-12-31) — Diluted Average Shares: 6521648.00
ADN1.DE income_statement (annual, 2023-12-31) — Diluted EPS: 0.49
ADN1.DE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 3205000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 0.00
ADN1.DE income_statement (annual, 2023-12-31) — EBIT: 23467000.00
ADN1.DE income_statement (annual, 2023-12-31) — EBITDA: 81190000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -314000.00
ADN1.DE cash_flow (annual, 2023-12-31) — End Cash Position: 100772000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Financing Cash Flow: -15889000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Free Cash Flow: 42515000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 6000.00
ADN1.DE income_statement (annual, 2023-12-31) — General And Administrative Expense: 11366000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Goodwill: 98098000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 141034000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Gross PPE: 223783000.00
ADN1.DE income_statement (annual, 2023-12-31) — Gross Profit: 324135000.00
ADN1.DE income_statement (annual, 2023-12-31) — Interest Expense: 11274000.00
ADN1.DE income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 11274000.00
ADN1.DE income_statement (annual, 2023-12-31) — Interest Income: 2398000.00
ADN1.DE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2398000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Interest Paid Cff: -9659000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Interest Received Cfi: 653000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Invested Capital: 194416000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -50782000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 20748000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 417000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 147792000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Long Term Debt: 98333000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 147792000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 2224000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Long Term Provisions: 5128000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 22566000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Minority Interest: 4777000.00
ADN1.DE income_statement (annual, 2023-12-31) — Minority Interests: -205000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -12670000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 417000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Net Debt: 5928000.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Income: 3205000.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 3205000.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 3410000.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 3205000.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 3205000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 12193000.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 3410000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -7969000.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Interest Income: -8876000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -4547000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
ADN1.DE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -8876000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 26926000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Net PPE: 223783000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -26249000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 53382000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 10974000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 6423000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 11123000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 6348000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 1557000.00
ADN1.DE income_statement (annual, 2023-12-31) — Normalized EBITDA: 80056000.00
ADN1.DE income_statement (annual, 2023-12-31) — Normalized Income: 2241100.00
ADN1.DE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 76860000.00
ADN1.DE income_statement (annual, 2023-12-31) — Operating Income: 17843000.00
ADN1.DE income_statement (annual, 2023-12-31) — Operating Revenue: 1135903000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 6520272.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Current Assets: 20554000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 129117000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 42936000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 12460000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 854000.00
ADN1.DE income_statement (annual, 2023-12-31) — Other Operating Expenses: 96690000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Payable: 73606000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Properties: 223783000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Receivables: 74325000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 2284000.00
ADN1.DE income_statement (annual, 2023-12-31) — Other Special Charges: -1725000.00
ADN1.DE income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Payables: 52337000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 82962000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Prepaid Assets: 47000.00
ADN1.DE income_statement (annual, 2023-12-31) — Pretax Income: 12193000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Properties: 0.00
ADN1.DE cash_flow (annual, 2023-12-31) — Purchase Of Business: -1145000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -7969000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -9389000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -26376000.00
ADN1.DE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 811768000.00
ADN1.DE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 57723000.00
ADN1.DE income_statement (annual, 2023-12-31) — Rent And Landing Fees: 124000.00
ADN1.DE income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 124000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
ADN1.DE income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -455000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Retained Earnings: 143822000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Sale Of Business: 108000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Sale Of Intangibles: 0.00
ADN1.DE cash_flow (annual, 2023-12-31) — Sale Of Investment: 4842000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Sale Of PPE: 127000.00
ADN1.DE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 10039000.00
ADN1.DE income_statement (annual, 2023-12-31) — Selling General And Administration: 21405000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Share Issued: 6520272.00
ADN1.DE income_statement (annual, 2023-12-31) — Special Income Charges: 1206000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 194416000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 53382000.00
ADN1.DE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 170100.00
ADN1.DE income_statement (annual, 2023-12-31) — Tax Provision: 8783000.00
ADN1.DE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.15
ADN1.DE balance_sheet (annual, 2023-12-31) — Taxes Receivable: 6781000.00
ADN1.DE cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -19784000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Assets: 781675000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Capitalization: 194416000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Debt: 178823000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 199193000.00
ADN1.DE income_statement (annual, 2023-12-31) — Total Expenses: 1118060000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 582482000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 395066000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 302306000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 6002000.00
ADN1.DE income_statement (annual, 2023-12-31) — Total Unusual Items: 1134000.00
ADN1.DE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 1134000.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ADN1.DE balance_sheet (annual, 2023-12-31) — Working Capital: 106433000.00
ADN1.DE income_statement (annual, 2023-12-31) — Write Off: 519000.00
ADN1.DE cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: 0.00
ADN1.DE cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 100000.00
ADN1.DE cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 100000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — +Operating Expense: 188646000.00
ADN1.DE income_statement (annual, 2024-12-31) — +Total Revenue: 1285945000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — +Total Revenue: 335693000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 41014000.00
ADN1.DE income_statement (annual, 2024-12-31) — Basic EPS: 0.41
ADN1.DE cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 41475000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Capital Expenditure: -36597000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -7939000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: -1545000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 40938000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: 65948000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Change In Working Capital: 38955000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 64586000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Changes In Cash: -10737000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Changes In Cash: 48140000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 175330000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -8180000.00
ADN1.DE income_statement (annual, 2024-12-31) — Cost Of Revenue: 923508000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 136352000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Current Assets: 364034000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Current Liabilities: 334797000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Depreciation: 18550000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 18550000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 18550000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 18550000.00
ADN1.DE income_statement (annual, 2024-12-31) — Diluted EPS: 0.41
ADN1.DE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 2655000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 7077000.00
ADN1.DE income_statement (annual, 2024-12-31) — EBIT: 28435000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — EBIT: 13961000.00
ADN1.DE income_statement (annual, 2024-12-31) — EBITDA: 95938000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — EBITDA: 32511000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 66000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — End Cash Position: 89682000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -37752000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Free Cash Flow: 81420000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 85603000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 149357000.00
ADN1.DE income_statement (annual, 2024-12-31) — Gross Profit: 362437000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Gross Profit: 199341000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Interest Expense: 4264000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 4264000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Interest Income: 989000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 989000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Interest Paid Cff: -3758000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Interest Received Cfi: 573000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Invested Capital: 268563000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -41132000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -7650000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
ADN1.DE income_statement (annual, 2024-12-31) — Minority Interests: -1497000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Minority Interests: -672000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -1377000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -8180000.00
ADN1.DE income_statement (annual, 2024-12-31) — Net Income: 2655000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Income: 7077000.00
ADN1.DE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 2655000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 7077000.00
ADN1.DE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 4152000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 7749000.00
ADN1.DE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 2655000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 7077000.00
ADN1.DE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 2655000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 7077000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 13443000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 9697000.00
ADN1.DE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 4152000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 7749000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -18937000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -4064000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Interest Income: -3275000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 933000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -3275000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -14545000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -3715000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 25973000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 11284000.00
ADN1.DE balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 11284000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 12175000.00
ADN1.DE income_statement (annual, 2024-12-31) — Normalized EBITDA: 95789000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 31647000.00
ADN1.DE income_statement (annual, 2024-12-31) — Normalized Income: 2528350.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Normalized Income: 6386566.26
ADN1.DE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 118017000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 93542000.00
ADN1.DE income_statement (annual, 2024-12-31) — Operating Income: 25416000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Operating Income: 10695000.00
ADN1.DE income_statement (annual, 2024-12-31) — Operating Revenue: 1285945000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Operating Revenue: 335693000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Other Current Assets: 22365000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 23919000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 49224000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 5466000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Other Operating Expenses: -9291000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Other Receivables: 55622000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 93182000.00
ADN1.DE balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 93182000.00
ADN1.DE income_statement (annual, 2024-12-31) — Pretax Income: 13443000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Pretax Income: 9697000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 70000.00
ADN1.DE cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -18937000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -4064000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 536000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -3875000.00
ADN1.DE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 923508000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 136352000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 18550000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -8180000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Retained Earnings: 135719000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 397000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Special Income Charges: 1576000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 175330000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 25973000.00
ADN1.DE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 22350.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 173566.26
ADN1.DE income_statement (annual, 2024-12-31) — Tax Provision: 9291000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Tax Provision: 1948000.00
ADN1.DE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
ADN1.DE income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.20
ADN1.DE balance_sheet (annual, 2024-12-31) — Taxes Receivable: 10429000.00
ADN1.DE cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: -4934000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Total Assets: 792805000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Total Capitalization: 252990000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 179274000.00
ADN1.DE income_statement (annual, 2024-12-31) — Total Expenses: 1260529000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Total Expenses: 324998000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 613531000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 428771000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 278734000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Total Unusual Items: 864000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 864000.00
ADN1.DE balance_sheet (annual, 2024-12-31) — Working Capital: 29237000.00
ADN1.DE income_statement (quarterly, 2024-12-31) — Write Off: 224000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — +Operating Expense: 53140000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — +Total Revenue: 351249000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 57693000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 165929000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 41839000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 6522272.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Basic EPS: -1.02
ADN1.DE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 89682000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -10069000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 194456000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6522000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 50235000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 52702000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -271000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Cash Financial: 50235000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -56572000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -56695000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -39187000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Common Stock: 6522000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 184346000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -1844000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 297939000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Current Assets: 388896000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 38138000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 38138000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 323772000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Current Provisions: 8899000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Depreciation: 17571000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 17571000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 17571000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 17571000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 6522272.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.02
ADN1.DE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -6591000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 0.00
ADN1.DE income_statement (quarterly, 2025-03-31) — EBIT: -174000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — EBITDA: 17397000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -260000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — End Cash Position: 50235000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 9547000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -51465000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Goodwill: 100057000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 139021000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 240451000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Gross Profit: 53310000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Interest Expense: 2867000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2867000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Interest Income: 404000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 404000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -2605000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Interest Received Cfi: 148000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 184346000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -7338000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 22810000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 156318000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 156318000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3950000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 2449000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 3441000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Minority Interests: 745000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -1844000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Income: -6591000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -6591000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7336000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -6591000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -6591000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3041000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7336000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -5255000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Interest Income: -2463000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 2583000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2463000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 24674000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Net PPE: 240451000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -4814000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 45325000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 20328000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4628000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 15598000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 18054000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Normalized Income: -6032550.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -41396000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Operating Income: 170000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Operating Revenue: 351249000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 6401181.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 24560000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 136796000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 38964000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2910000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 951000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 38336000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Other Properties: 240451000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 134674000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2467000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Payables: 68906000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Pretax Income: -3041000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -5255000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -522000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -4814000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 297939000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 17571000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -1844000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 145995000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 3105000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Share Issued: 6522272.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Special Income Charges: -582000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 184346000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 45325000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -98550.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Tax Provision: 4295000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 11031000.00
ADN1.DE cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -2232000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Assets: 816407000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 184346000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Debt: 194456000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 187787000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Total Expenses: 351079000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 628620000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 427511000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 304848000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 11213000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -657000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -657000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 121091.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 9998000.00
ADN1.DE balance_sheet (quarterly, 2025-03-31) — Working Capital: 65124000.00
ADN1.DE income_statement (quarterly, 2025-03-31) — Write Off: 582000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — +Operating Expense: 53523000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — +Total Revenue: 356136000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 67486000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 190383000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 42781000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 50235000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -7303000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 190871000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 6522000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 44878000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 48071000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -4801000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Cash Financial: 44878000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -18992000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -16442000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -5304000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 6522000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 178123000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 300428000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 415671000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 39112000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 39112000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 329407000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Current Provisions: 10936000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Depreciation: 17458000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 17458000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 17458000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 17458000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2184000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Dividends Received Cfi: 0.00
ADN1.DE income_statement (quarterly, 2025-06-30) — EBIT: 1013000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — EBITDA: 18471000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -53000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — End Cash Position: 44878000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 7811000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -8783000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Goodwill: 100103000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 141796000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 234168000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Gross Profit: 55708000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Interest Expense: 3259000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3259000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Interest Income: 448000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 448000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -3027000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 235000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 178123000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -11635000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 25037000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 151759000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 151759000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 4288000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 2649000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 3261000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Minority Interests: -292000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -1640000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Income: -2184000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2184000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1892000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2184000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2184000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2246000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1892000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -5548000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Interest Income: -2811000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -2927000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2811000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 25770000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 234168000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1755000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 36327000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 21649000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 3647000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 16059000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 18776000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Normalized Income: -1927072.13
ADN1.DE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1480000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Operating Income: 2185000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Operating Revenue: 356136000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 6401181.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 28384000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 141042000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 41693000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 4768000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 914000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 151759000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 40740000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Properties: 234168000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 135643000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 3193000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Payables: 76504000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Pretax Income: -2246000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -1640000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -5548000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -3223000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1755000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 300428000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 17458000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 139011000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 296000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Share Issued: 6522272.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Special Income Charges: -303000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 178123000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 36327000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -48072.13
ADN1.DE income_statement (quarterly, 2025-06-30) — Tax Provision: -354000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.16
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 13190000.00
ADN1.DE cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -6301000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Assets: 843523000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 178123000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Debt: 190871000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 181384000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Total Expenses: 353951000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 662139000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 427852000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 332732000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 9018000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Total Unusual Items: -305000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -305000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 121091.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 9998000.00
ADN1.DE balance_sheet (quarterly, 2025-06-30) — Working Capital: 86264000.00
ADN1.DE income_statement (quarterly, 2025-06-30) — Write Off: 303000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — +Operating Expense: 52424000.00